By. Neil Carleton, MD Date. 12/07/2023 In the interview with Neil Carleton, MD, the discussion revolved…

In an ongoing Phase 1/2 study, Constantine Tam, MD, a researcher and Professor of Haematology,…

By: Hope Rugo, MD Date: 12/9/2023 At the SABCS 2023 conference, medical oncologist Hope Rugo…

Jeff Sharman, MD, a medical oncologist at the Willamette Ballet Cancer Institute and Research Center,…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…

By. Terry Mamounas Date: 12/07/2023In a collaborative study between NVP and RT, led by oncologist…

At ASH 2023, there is a discussion with Dr. Davide Matino, Assistant Professor of Medicine at…

By: Yara Abdou, MD, Date. 12/08/2023 At SABCS 2023, Yara Abdou, MD, a medical oncologist…

At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina,…